AIBORN Receives Investment from Medical Data Vision

AIBORN, a company based in Chuo-ku, Tokyo, that develops the medical record AI tool Katanashi, has announced a new investment from Medical Data Vision Inc. (MDV). This capital and business alliance aims to deepen the partnership between the two companies as MDV works to expand the adoption of AIBORNs software across medical institutions in Japan.

Investors

Medical Data Vision Inc. (MDV), a company that manages a large medical database in Japan, participated in this investment round.

AIBORN Use of Funds

The funding and alliance will be used to strengthen collaboration between AIBORN and MDV regarding product development, the provision of Katanashi to medical institutions, and the enhancement of post-implementation support for healthcare professionals.

About AIBORN

Founded in Tokyo, AIBORN is led by President and CEO Shohei Toyama. The company focuses on reducing the administrative burden of healthcare professionals through their AI-powered medical record tool, Katanashi. The software transcribes patient consultations and meetings, automatically summarizing them into formats like SOAP to streamline clinical documentation.

Funding Details

Company Website: https://aiborn.co.jp

Company: AIBORN Co., Ltd.
Funding Date: October 1, 2026
Additional Investors: Medical Data Vision Inc.
Company Website: https://aiborn.co.jp/
Software Category: Healthcare IT
Source: https://prtimes.jp/main/html/rd/p/000000001.000191863.html